LOS ANGELES, Feb. 18, 2011 /PRNewswire/ -- UBM Canon and IVD Technology are proud to announce the first webcast in a new educational lecture series on Challenges in Immunoassay Development. This webcast will take place on February 24, 2011 at 2:00 p.m. ET (1:00 p.m. CT, 11:00 a.m. PT). Registration is available here.
This one-hour educational lecture will be given by Professor Svetlana A. Dambinova, PhD, from Wellstar College of Health and Human Services, Kennesaw State University. Dambinova will discuss challenges in immunoassay development and the issues that IVD manufacturers face during the assay development process. Live Q&A will follow the presentation.
Richard Park, Editor-in-Chief of IVD Technology stated, "This new webcast series will provide educational resources to our IVD audience that focuses on the issues they are facing in their daily jobs. Since the 1960s, immunoassays have continued to make enormous contributions to clinical lab medicine and have become one of the primary and indispensable tools in the diagnosis and monitoring of all areas of disease. The potential of this class of tests is now even more impressive. This webcast will address these contributions to medicine as well as the challenges involved in assay development."
The sponsor for this webcast is AbD Serotec.
For more information on the Challenges in Immunoassay Development webcast, click here.
About UBM Canon
UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM (UBM.L) a global provider of media and information services for professional B2B communities and markets.
SOURCE UBM Canon